Similar to our founding RO3306 could induce G2/M cell cycle arrest in colorectal cancer cells, colon cancer cells, cervical cancer cells, ovarian cancer cells, hepatocellular cancer cells and MYC-dependent human breast cancer cells 19, 46, 50, 53. Here, MYC is linked to cervical cancer.